Editorial
Copyright ©The Author(s) 2024.
World J Gastroenterol. Jun 21, 2024; 30(23): 2934-2946
Published online Jun 21, 2024. doi: 10.3748/wjg.v30.i23.2934
Table 2 Pathways regulating mitophagy in gastric cancer, colorectal cancer, and inflammatory bowel diseases
Diseases
Molecules
Effects/mechanisms
Significance
Ref.
Gastric cancerYapActivates the SIRT1/Mfn2/mitophagy axis. Knockdown of Yap impairs the expression of adhesive proteins, reduces F-actin expression, and inhibits lamellipodium formationTumor-promoting effects: It contributes to the migration and survival of gastric cancer cells[63]
GGT7Binds with the mitophagy regulator RAB7 to induce mitophagy. GGT7 inhibits ROS production and MAPK cascadesTumor-suppressing effect: It inhibits the growth, G1-S phase transition and migration of gastric cancer cells[64]
CRCpiR823Promotes ubiquitination and proteasome-dependent degradation of PINK1, thereby inhibiting mitophagyTumor-promoting
effects: It is involved in CRC tumorigenesis
[71]
MST1Inhibits mitophagy through the JNK/p53/BNIP3 pathway, leading to oxidative stress and initiating mitochondria-mediated apoptosisTumor-suppressing effect: It inhibits tumor proliferation[73]
GPR176Inhibits mitophagy through the cAMP/PKA/BNIP3L axisTumor-promoting effects: It promotes the development of CRC[74]
IBDNR1D1Acts as a positive regulator of BNIP3 expression, promoting mitophagy and maintaining the immune homeostasis of IECsInhibitory effect on colitis: It reduces the severity and progression of colitis[88]